Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease

QR Code

Update on the use of pramipexole in the treatment of Parkinson&rsquo;s disease

Radu ConstantinescuDepartment of Neurology, Sahlgrenska University Hospital, 413 45 G&ouml;teborg, SwedenAbstract: Pramipexole is a non-ergot dopamine agonist shown to be efficacious in the treatment of Parkinson&rsquo;s disease (PD). This review addresses the literature concerning p...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Radu Constantinescu
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/17db5ca1eeb748cd82866c37b72f19e4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Beneficial effect of pramipexole for motor function and depression in Parkinson&rsquo;s disease
par: Osamu Kano, et autres
Publié: (2009)

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson&rsquo;s disease: implications for patients
par: Antonini A, et autres
Publié: (2011)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
par: Holly A Shill, et autres
Publié: (2008)

Rasagiline in treatment of Parkinson&rsquo;s disease
par: Lakshmi Nayak, et autres
Publié: (2008)

Current approaches to the treatment of Parkinson&rsquo;s disease
par: Joseph Jankovic, et autres
Publié: (2008)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
par: Jennifer L Reingold, et autres
Publié: (2007)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
par: Emma L Lane, et autres
Publié: (2008)

Sleep disorders in Parkinson&rsquo;s disease
par: Israt Jahan, et autres
Publié: (2009)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
par: J&uuml;rgen G&ouml;tz, et autres
Publié: (2008)

Update on the use of memantine in Alzheimer&rsquo;s disease
par: Robert J van Marum
Publié: (2009)

Depression in Parkinson&rsquo;s disease: Health risks, etiology, and treatment options
par: Pasquale G Frisina, et autres
Publié: (2008)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
par: Kristinsson J, et autres
Publié: (2012)

Parkinson&rsquo;s disease and the frequent reasons for emergency admission
par: Ozlem Guneysel, et autres
Publié: (2008)

Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
par: Combs BL, et autres
Publié: (2017)

Psychiatric disorders in primary focal dystonia and in Parkinson&rsquo;s disease
par: Fernando MV Dias, et autres
Publié: (2011)

A randomized controlled trial of quetiapine for psychosis in Parkinson&rsquo;s disease
par: Paul Shotbolt, et autres
Publié: (2009)

Depressive symptoms in Parkinson&rsquo;s disease and in non-neurological medical illnesses
par: Assogna F, et autres
Publié: (2013)

Daytime sleepiness in elderly Parkinson&rsquo;s disease patients and treatment with the psychostimulant modafinil: A preliminary study
par: Johan L&ouml;kk
Publié: (2010)

Parkinson&rsquo;s disease patients&rsquo; subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
par: Skogar &Ouml;, et autres
Publié: (2012)

Did depressive symptoms affect recognition of emotional prosody in Parkinson&rsquo;s disease?
par: Adriana V&eacute;lez Feij&oacute;, et autres
Publié: (2008)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
par: Bargiotas P, et autres
Publié: (2013)

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson&rsquo;s disease (PD): relevance for motor and non-motor features
par: Angelo Antonini, et autres
Publié: (2008)

Aripiprazole in the treatment of Huntington&rsquo;s disease: a case series
par: Andrea Ciammola, et autres
Publié: (2008)

Parkinson’s disease-associated melanin steal
par: Hinz M, et autres
Publié: (2014)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice
par: Seibert J, et autres
Publié: (2012)

Review: management of Parkinson&#39;s disease
par: Pedrosa DJ, et autres
Publié: (2013)

Optimizing levodopa therapy for Parkinson&rsquo;s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
par: David J Brooks
Publié: (2008)

Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China
par: Zou YM, et autres
Publié: (2015)

Prevalence of Parkinson’s disease and other types of Parkinsonism in Al Kharga district, Egypt
par: El-Tallawy HN, et autres
Publié: (2013)

Social phobia in Parkinson’s disease: Prevalence and risk factors
par: Gultekin BK, et autres
Publié: (2014)

Brain amyloid &beta; protein and memory disruption in Alzheimer&rsquo;s disease
par: Weiming Xia
Publié: (2010)

Do physical exercise and reading reduce the risk of Parkinson’s disease? a cross-sectional study on factors associated with Parkinson’s disease in elderly Chinese veterans
par: Zou YM, et autres
Publié: (2015)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
par: Umamon Puangthong, et autres
Publié: (2009)

Neuro-Beh&ccedil;et&rsquo;s disease: A report of sixteen patients
par: Radi Shahien, et autres
Publié: (2010)

Adjunctive therapy in Parkinson&#39;s disease: the role of rasagiline
par: Gaines KD, et autres
Publié: (2012)

Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
par: Zhang W, et autres
Publié: (2013)

A review of the potential therapeutic role of statins in the treatment of Alzheimer&rsquo;s disease: current research and opinion
par: Mitchell AJ, et autres
Publié: (2013)

Intrathecal corticosteroids might slow Alzheimer&rsquo;s disease progression
par: Joseph Martin Alisky
Publié: (2008)

Present and prospective clinical therapeutic regimens for Alzheimer&rsquo;s disease
par: Mustafa M Husain, et autres
Publié: (2008)

The impact of nocturnal disturbances on daily quality of life in patients with Parkinson’s disease
par: Yu RL, et autres
Publié: (2015)